PTX3 inhibits angiogenesis Selective recognition of fibroblast growth factor-2 by the long pentraxin
暂无分享,去创建一个
Barbara Bottazzi | Marco Presta | Alberto Mantovani | Marco Rusnati | A. Mantovani | S. Indraccolo | A. Amadori | G. Peri | M. Rusnati | M. Presta | E. Moroni | Maura Camozzi | Alberto Amadori | Giuseppe Peri | Stefano Indraccolo | B. Bottazzi | M. Camozzi | Emanuela Moroni | A. Mantovani
[1] M. Rocchi,et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. , 1992, The Journal of biological chemistry.
[2] J. Vilček,et al. TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. , 1993, Journal of immunology.
[3] A. Mantovani,et al. Long Pentraxin PTX3 Upregulates Tissue Factor Expression in Human Endothelial Cells: A Novel Link Between Vascular Inflammation and Clotting Activation , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[4] H. Land,et al. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.
[5] G. Taraboletti,et al. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[6] M. Nugent,et al. Endothelial proteoglycans inhibit bFGF binding and mitogenesis , 1997, Journal of cellular physiology.
[7] A. Mantovani,et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. , 2001, Arthritis and rheumatism.
[8] M. Reidy,et al. Factors controlling the development of arterial lesions after injury. , 1992, Circulation.
[9] M. Presta,et al. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration , 1986, Molecular and cellular biology.
[10] C. Blobel,et al. Apexin, an acrosomal pentaxin. , 1994, The Journal of biological chemistry.
[11] B. Matthews,et al. Three-dimensional structure of human basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Capogrossi,et al. Platelet-derived Growth Factor-BB and Basic Fibroblast Growth Factor Directly Interact in Vitro with High Affinity* , 2002, The Journal of Biological Chemistry.
[13] T. Fan,et al. Quantification of the repair process involved in the repair of a cell monolayer using an in vitro model of mechanical injury , 2004, Angiogenesis.
[14] M. Rusnati,et al. Basic fibroblast growth factor: Production, mitogenic response, and post‐receptor signal transduction in cultured normal and transformed fetal bovine aortic endothelial cells , 1989, Journal of cellular physiology.
[15] D. Rifkin,et al. Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.
[16] A Vacca,et al. Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[17] C. Garlanda,et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. , 2000, Blood.
[18] D. Rifkin,et al. Alpha 2-macroglobulin is a binding protein for basic fibroblast growth factor. , 1989, The Journal of biological chemistry.
[19] T. Eberlein,et al. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[20] C. Garlanda,et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response , 2002, Nature.
[21] G Olivetti,et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. , 2000, Circulation.
[22] C. Gajdusek,et al. Injury‐induced release of basic fibroblast growth factor from bovine aortic endothelium , 1989, Journal of cellular physiology.
[23] A. Isacchi,et al. A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Bikfalvi,et al. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. , 1998, Blood.
[25] M. Nugent,et al. Fibroblast growth factor-2. , 2000, The international journal of biochemistry & cell biology.
[26] L. Orci,et al. Plasminogen activator inhibitor‐1 is induced in migrating endothelial cells , 1992, Journal of cellular physiology.
[27] C. Garlanda,et al. Production of the Long Pentraxin PTX3 in Advanced Atherosclerotic Plaques , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[28] D. Gospodarowicz,et al. The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. , 1985, The Journal of biological chemistry.
[29] Francesco Tedesco,et al. Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 , 1997, The Journal of Biological Chemistry.
[30] M. Matsumoto,et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Moscatelli,et al. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.
[32] A. Mantovani,et al. Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice , 2004, Angiogenesis.
[33] L. Reis,et al. TSG‐14 transgenic mice have improved survival to endotoxemia and to CLP‐induced sepsis , 2001, Journal of leukocyte biology.
[34] C. Garlanda,et al. Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration , 2001, Neuroscience.
[35] M. Rusnati,et al. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans , 1996, International journal of clinical & laboratory research.
[36] T. Blundell,et al. Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. , 1996, Blood.
[37] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[38] R. Abagyan,et al. Long pentraxins: an emerging group of proteins with diverse functions. , 1996, Cytokine & growth factor reviews.
[39] E. De Clercq,et al. Inhibition of Fibroblast Growth Factor-2-induced Vascular Tumor Formation by the Acyclic Nucleoside Phosphonate Cidofovir 1 , 2001 .
[40] T. Eberlein,et al. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] A Vacca,et al. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. , 1997, Journal of vascular research.
[42] D. Rifkin,et al. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum‐Golgi complex , 1992, Journal of cellular physiology.
[43] R. Gallo,et al. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. , 1997, Journal of immunology.
[44] S. Tapscott,et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[45] L. Morbidelli,et al. Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. , 1993, The Journal of clinical investigation.
[46] M. Byrne,et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. , 2002, Molecular endocrinology.
[47] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[48] P. Dell’Era,et al. Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. , 1991, Experimental cell research.
[49] M. Berry,et al. Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS. , 1993, Trends in pharmacological sciences.
[50] A. Mantovani,et al. Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan , 1997, Infection and immunity.
[51] H. Augustin,et al. Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 (MCP-1) in autocrine-activated endothelial cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[52] J. Folkman,et al. Angiogenic factors. , 1987, Science.
[53] C. Barnes,et al. Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[54] M. Ziche,et al. Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. , 1999, Molecular biology of the cell.
[55] D. Becker,et al. Antisense targeting of basic fibroblast growth factor and dibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth , 1997, Nature Medicine.
[56] A. Wellstein,et al. An FGF‐binding protein (FGF‐BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF‐2 release , 2001, International journal of cancer.
[57] D. Moscatelli,et al. The FGF family of growth factors and oncogenes. , 1992, Advances in cancer research.
[58] A. Mantovani,et al. Inducible expression of the long pentraxin PTX3 in the central nervous system , 2000, Journal of Neuroimmunology.
[59] H. Granger,et al. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. , 1997, Circulation research.
[60] A. Mantovani,et al. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA) , 2000, Clinical and experimental immunology.
[61] D. McDonald,et al. Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. , 2001, The American journal of pathology.
[62] Y. Hsu,et al. Human neuronal pentraxin II (NPTX2): conservation, genomic structure, and chromosomal localization. , 1995, Genomics.
[63] E. Levine,et al. Bovine endothelial cells transformed in vitro by benzo(a)pyrene , 1983, Journal of cellular physiology.
[64] E. Rofstad,et al. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. , 2000, Cancer research.
[65] V. Torri,et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients , 2001, Critical care medicine.